The South African Health Products Regulatory Authority (SAHPRA) hereby invites industry stakeholders to a consultative meeting aimed at receiving updates and feedback from applicants on the functionality of the Digital CTF1 Application Module. The purpose of this engagement is to provide a platform for industry...
The South African Health Products Authority (SAHPRA) hosted a Webinar on reporting of Adverse Effects Following Immunisation (AEFI) and Launch of the VigiMobile App for Healthcare Professionals (HCPs). AEFI surveillance is a key component of the National Expanded Programme on Immunisation (EPI) and depends on...
The South African Health Products Authority (SAHPRA) hosted a Webinar on reporting of Adverse Effects Following Immunisation (AEFI) and Launch of the VigiMobile App for Healthcare Professionals (HCPs). AEFI surveillance is a key component of the National Expanded Programme on Immunisation (EPI) and depends on...
The South African Health Products Regulatory Authority (SAHPRA) hosted an engagement session focused on training and guidance regarding SAHPRA’s requirements for Adverse Event reporting. The purpose of the engagement was to enhance industry understanding and facilitate the effective implementation of Regulation 17 of the...
The South African Health Products Regulatory Authority (SAHPRA) hosted a workshop on the Medical Devices Voluntary Product Registration Feasibility Study – Phase Two. The purpose of the workshop was to engage stakeholders and discuss the Expression of Interest (EOI) process for participation in the...
The South African Health Products Regulatory Authority (SAHPRA) cordially invites you to attend the official online launch of the Prescription-Only Medicines (Rx) Section of the SAHPRA Online Medicines Directory. SAHPRA successfully launched the Over-the-Counter (OTC) Online Medicines Directory in June 2022 as the first phase of this initiative....
